Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer. [electronic resource]
Producer: 20140819Description: 1579-84 p. digitalISSN:- 1531-4995
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Squamous Cell -- diagnosis
- Cetuximab
- Combined Modality Therapy
- Disease-Free Survival
- ErbB Receptors
- Female
- Follow-Up Studies
- Head and Neck Neoplasms -- diagnosis
- Humans
- Incidence
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- epidemiology
- Neoplasm Staging
- Quality of Life
- Radiosurgery -- methods
- Radiotherapy Dosage
- Radiotherapy, Adjuvant -- methods
- Retrospective Studies
- Salvage Therapy -- methods
- Squamous Cell Carcinoma of Head and Neck
- Survival Rate -- trends
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.